Antibe Therapeutics Inc(Pre-Merger) T.ATE

Primary Symbol: ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > What you see now

<< Previous

Bullboard Posts

Next >>

Comment by JimmyJon Jun 19, 2021 9:15am

230 Views

Post# 33416413

RE:RE:RE:RE:RE:What you see now

woundedknee wrote: Mugsy..never questioned the science or the pipeline of potential blockbuster drugs this company has in its pipeline. I think it's an amazing investment opportunity. But it seems just when the door starts to open up for a potential share price increase Dan's poor judgement, imo, stifles that gain. Sometimes, in the heat of the moment my responses may also reflect poor judgement. You and others may disagree with me and that is your right, as long as it leads to healthy debate.
So I would like you to answer this simple question. Do you think that Dan's and Walter's sales had anything to do with this temporary sell down

Antibe will remain a loser until it's a winner. Read these and then answer your own question.

https://www.investopedia.com/articles/trading/06/biotechsector.asp

https://www.investopedia.com/articles/fundamental-analysis/11/primer-on-biotech-sector.asp

Of course the Dan and Walter's sale affects the SP, it's rare a sale doesn't affect it. But ask yourself, does it really matter at this point? Did you invest in ATE for the short term or the big win? The odds are still stacked against Antibe at this stage and will remain so until they have a clear path to revenue. At that moment you got a winner and it can't be timed. This will remain a "buy the hype, sell the news" stock until that moment. But it can do the other way to $0. That's the cycle of biotech.

I'm betting it's a winner but ready to lost it all. Took me over 5 years for my last big win and it was worth the wait.